At Gendius we are continuously working with clinical bodies to improve outcomes of patients with diabetes and gather valuable information to improve the Intellin platform. Read below to find out more.
Personalised apps for management and monitoring of gestational diabetes
A survey of patients’ and physicians’ attitudes
Induce (Intellin Diabetic Foot) Feasibility Study
Trial identifier NCT03591081, S18DIAB04-S